Challenging the drug-likeness dogma for new drug discovery in Tuberculosis
The emergence of multi- and extensively drug resistant tuberculosis worldwide poses a great threat to human health and highlight the need to discover and develop new, effective and inexpensive antituberculosis agents. High-throughput screening assays against well-validated drug targets and structure...
| Autor principal: | |
|---|---|
| Outros Autores: | , , |
| Formato: | review |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10362/116865 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/116865 |